Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CASTLE BIOSCIENCES INC Director's Dealing 2020

Aug 14, 2020

32601_dirs_2020-08-14_8896f5fb-1759-40b7-814d-21b73c63b0da.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CASTLE BIOSCIENCES INC (CSTL)
CIK: 0001447362
Period of Report: 2020-08-12

Reporting Person: MAETZOLD DEREK J (Director, Pres. & Chief Exec. Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-08-12 Common Stock S 800 $40.297 Disposed 1563048 Direct
2020-08-12 Common Stock S 4200 $41.903 Disposed 1558848 Direct
2020-08-13 Common Stock S 7300 $40.973 Disposed 1551548 Direct
2020-08-13 Common Stock S 200 $41.70 Disposed 1551348 Direct
2020-08-13 Common Stock S 1000 $40.909 Disposed 1550348 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 159329 Indirect

Footnotes

F1: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on June 2, 2020.

F2: This transaction was executed in multiple trades at prices ranging from $39.940 to $40.765, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F3: This transaction was executed in multiple trades at prices ranging from $41.520 to $42.240, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F4: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on March 18, 2020.

F5: This transaction was executed in multiple trades at prices ranging from $40.670 to $41.635, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F6: This transaction was executed in multiple trades at prices ranging from $40.690 to $41.110, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F7: Held by the DJM Grantor Retained Annuity Trust No. 1, or the Maetzold Trust. The Reporting Person is a trustee of the Maetzold Trust.